Clinical trial
Chemotherapy in Treating Patients With Retinoblastoma
NCT00002675 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00002675 |
|---|---|
| Title | Chemotherapy in Treating Patients With Retinoblastoma |
| Official title | A TRIAL OF ADJUVANT CHEMOTHERAPY IN PATIENTS WITH INTRAOCULAR RETINOBLASTOMA |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Retinoblastoma |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, carboplatin, cisplatin, cyclophosphamide, etoposide, mesna, vincristine sulfate |
| Enrollment | 50 |
| Start date | May 1, 1995 |
| Primary completion | Jan 1, 2001 |
| Completion | Jan 1, 2001 |
| First posted | Jul 29, 2004 |
| Last update posted | Jun 28, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: